Company: AEMD
Filing Date: 2025-02-12
Form Type: 10-Q
Source: 0001683168-25-000960
Chunk: 76

Company: AETHLON MEDICAL INC
Filing Date: 2025-02-12
Form: 10-Q
Item: Item 8
Chunk 76
---
-14(a) or 15d-14(a) of the Securities Exchange Act of 1934.

    X

    32.1^
     
    Certification of the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350.

    X

    101.INS*
     
    Inline XBRL Instance Document with Embedded Linkbase Documents 

    X

    101.SCH*
     
    Inline XBRL Taxonomy Extension Schema Document

    X

    104*
     
    Cover Page Interactive Data File (formatted in XBRL, and included in exhibit 101)

    ^
    The information in Exhibit 32.1 shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act (including this Quarterly Report), unless the Registrant specifically incorporates the foregoing information into those documents by reference.

    *
    The XBRL related information in Exhibit 101 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.

 31 

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

    AETHLON MEDICAL, INC.

    Date: February 12, 2025
    By:
    /s/ JAMES B. FRAKES

    JAMES B. FRAKES

    CHIEF EXECUTIVE OFFICER

    CHIEF FINANCIAL OFFICER

    (PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER) 

 32